Vertex
Vertex Appeals Ruling That Fertility Support for Casgevy Patients Would Violate Kickback Laws
A federal district court had ruled in favor of HHS, restricting Vertex's ability to provide fertility preservation services to Medicaid patients.
EC Approves Vertex's Kaftrio, Kalydeco Cystic Fibrosis Drug Combo for More Patients
The new approval makes the regimen an option for around 4,000 patients in the EU who have at least one non-class I CFTR mutation.
Court Sides With HHS, Blocking Vertex Program to Cover Fertility Services for Patients on Casgevy
HHS had argued that Vertex's plan to cover fertility services for some patients that took its gene therapy would violate anti-kickback and inducement laws.
NICE Recommends Vertex, CRISPR Therapeutics' Casgevy for Sickle Cell Under Managed Access Deal
The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.
HHS Calls Vertex's Case for Fertility Program a 'Distraction,' Urges Court to Rule in Its Favor
HHS is asking the court to affirm its Office of Inspector General's finding that paying for fertility services would run afoul of anti-kickback laws.
Dec 11, 2024
Nov 1, 2023